EP PerMed: cell and gene therapies in personalised medicine (CGT4PM2027)

EP PerMed: raku- ja geeniteraapiad personaalmeditsiinis (CGT4PM2027)

Only Estonian companies with a cell or gene therapy project in personalised medicine. Universities apply via ETAg.

Applications are open until 20.01.2027, 15:00. Up to €500,000 per application, covering up to 80% of eligible costs.

Checked on 03.11.2026 at eis.ee

Conditions and application on the EIS siteRemind me 3 days before the deadline

Who can apply

Legal form:
OÜ or AS
Number of employees:
no limit found
Company age:
no limit found

Read from the funder's page. Check the exact terms at the source.

Closes
20.01.2027, 15:00
Opened
04.11.2026
Maximum grant
€500,000
Support rate
80%
How it is awarded
competitive round
Funder
EIS: Enterprise and Innovation Foundation

What changed

  • 04.11.2026Status: Opens soon → Open
What changed in the register
All deadlines to your calendar (.ics)Report an error

How are applications decided?

As a competitive round: every application submitted by the deadline is assessed, and the best-scored ones are funded.

Remind me of this measure's deadlines

About this measure only: an e-mail 21 days before it opens, on the day it opens and 3 days before it closes. No newsletter, no ads.

We keep the address, the measure and the language; e-mails go through MailerLite and opens are not tracked. More about your data

Ajastus is a free register of business support in Estonia, run by lifkuru OÜ. Ajastus is not a funder and does not take applications. Before applying, confirm the terms on the EIS page.

See also

Other measures from EIS

All 164 measures in the register